Alerts will be sent to your verified email
Verify Email
JBCHEPHARM
|
JB Chem & Pharma
|
Eris Lifesciences
|
Pfizer
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.49 % | 17.74 % | 19.03 % |
|
5yr Avg Net Profit Margin
|
16.71 % | 22.76 % | 26.04 % |
|
Price to Book
|
7.86 | 8.49 | 5.57 |
|
P/E
|
39.4 | 62.59 | 29.06 |
|
5yr Avg Cash Conversion Cycle
|
7.58 Days | -54.68 Days | 21.86 Days |
|
5yr Average Interest Coverage Ratio
|
58.81 | 66.44 | 185.18 |
|
5yr Avg ROCE
|
23.05 % | 18.34 % | 23.84 % |
|
5yr Avg Operating Profit Margin
|
24.73 % | 34.43 % | 31.72 % |
|
5 yr average Debt to Equity
|
0.07 | 0.46 | 0.0 |
|
5yr CAGR Net Profit
|
8.05 % | -0.19 % | 76.68 % |
|
5yr Average Return on Assets
|
12.98 % | 12.4 % | 15.25 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
47.73 % | 54.83 % | 63.92 % |
|
Share Pledged by Promoters
|
0.0 | 16.93 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.27 % | 2.53 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
1.15 % | 6.42 % | 4.53 % |
|
JB Chem & Pharma
|
Eris Lifesciences
|
Pfizer
|
|---|